Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.
Rodrigues JG, Duarte HO, Gomes C, Balmaña M, Martins ÁM, Hensbergen PJ, de Ru AH, Lima J, Albergaria A, van Veelen PA, Wuhrer M, Gomes J, Reis CA.
Rodrigues JG, et al. Among authors: martins am.
Cell Oncol (Dordr). 2021 Aug;44(4):835-850. doi: 10.1007/s13402-021-00606-z. Epub 2021 Apr 13.
Cell Oncol (Dordr). 2021.
PMID: 33847896